A Discussion with Chris Lipinski and Barry Bunin
Recorded live September 13, 2018
We cut out some of the highlights from Collaborative Drug Discovery's Fall Webinar with Dr. Chris Lipinski himself. Peruse these titles and pick out your own highlight reel.
Beyond the Rule of 5 : Exceptions...
"There are more than a billion years of evolution at work using a completely different toolkit than what we used in the medicinal chemistry laboratory"
4-Scaffolds populate only a small part of chemistry...
"All of the evidence on traditional medicinal chemistry type compounds is that the scaffolds occupy only a small portion of the overall chemistry space"

The value of older assay data...
"Historically, chemical information holds it's value. How valuable is old biology data?"
Other posts you might be interested in
View All Posts
CDD Blog
19 min
June 6, 2025
Synthetic Lethality in Precision Oncology: Integrating AI-Driven Discovery with Data Management Platforms
Read More
CDD Blog
29 min
June 4, 2025
How to Choose the Right ELN or LIMS for Early-Stage Drug Discovery
Read More
CDD Blog
10 min
June 3, 2025
Chemical Registration in Drug Discovery
Read More